JGC
TXG icon

J. Goldman & Co’s 10x Genomics TXG Stock Holding History

J. Goldman & Co’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.23M Buy
+84,139
New +$2.2M 0.08% 271

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

J. Goldman & Co's TXG Position: Q2 2026 in Review

J. Goldman & Co opened a new position in 10x Genomics (TXG) in Q2 2026: 84,139 shares worth $3.23M. The stake represents 0.08% of the portfolio and ranks #271 among its holdings.

390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • J. Goldman & Co held 84,139 shares of 10x Genomics worth $3.23M as of Q2 2026.
  • 10x Genomics was a new J. Goldman & Co position in Q2 2026.
  • 10x Genomics made up 0.08% of J. Goldman & Co's portfolio in Q2 2026, its #271 holding.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.